Doxycycline for Cellulitis and Abscess
Doxycycline is an appropriate option for cellulitis when MRSA coverage is needed, but it requires combination with a beta-lactam (like amoxicillin) to cover streptococci; for abscesses, incision and drainage is primary treatment, with doxycycline reserved only for complicated cases requiring antibiotic therapy. 1
Treatment Algorithm for Cellulitis
Non-Purulent Cellulitis (No Drainage or Abscess)
- First-line therapy: Beta-lactams (cephalexin) targeting beta-hemolytic streptococci are recommended, as MRSA is an uncommon cause in this presentation 1, 2
- Doxycycline role: Reserve for patients who fail beta-lactam therapy or have systemic toxicity suggesting possible MRSA involvement 1
- If using doxycycline: Must combine with a beta-lactam (e.g., amoxicillin) to ensure adequate streptococcal coverage 1
- Duration: 5-10 days, individualized based on clinical response 1
Purulent Cellulitis (Drainage/Exudate Without Drainable Abscess)
- Empirical MRSA coverage is recommended pending culture results 1
- Doxycycline is an acceptable option as monotherapy in this setting, as streptococcal coverage is likely unnecessary 1
- Alternative agents: Clindamycin, TMP-SMX, or linezolid are equally appropriate 1
- Duration: 5-10 days based on clinical response 1
Treatment Algorithm for Abscesses
Simple Abscesses
- Incision and drainage is the primary and often sole treatment required 1
- Antibiotics (including doxycycline) are NOT routinely needed for simple abscesses 1
Complex Abscesses Requiring Antibiotics
Antibiotic therapy with doxycycline is indicated when abscesses are associated with: 1
- Severe or extensive disease involving multiple sites
- Rapid progression with associated cellulitis
- Signs of systemic illness
- Comorbidities or immunosuppression
- Extremes of age
- Difficult-to-drain locations (face, hand, genitalia)
- Septic phlebitis
- Lack of response to incision and drainage alone
For these complicated cases, doxycycline provides MRSA coverage and is an appropriate oral option 1
Key Clinical Distinctions
When Doxycycline Works Well
- Purulent cellulitis: Effective as monotherapy since MRSA is the primary concern and streptococci are unlikely 1
- Complicated abscesses with systemic features: Provides adequate MRSA coverage when antibiotics are indicated 1
- Failed beta-lactam therapy: Appropriate escalation for non-purulent cellulitis not responding to initial treatment 1, 3
When Doxycycline Requires Combination Therapy
- Non-purulent cellulitis: Must add a beta-lactam (amoxicillin) to cover streptococci, as doxycycline alone has inadequate streptococcal activity 1
When Doxycycline Should NOT Be Used
- Children under 8 years of age: Tetracyclines are contraindicated due to tooth discoloration and bone growth effects 1
- Simple abscesses after adequate drainage: No antibiotics needed regardless of agent 1
Common Pitfalls to Avoid
- Do not use doxycycline monotherapy for non-purulent cellulitis without adding beta-lactam coverage for streptococci 1
- Do not prescribe antibiotics for simple abscesses that have been adequately drained 1
- Do not assume all cellulitis requires MRSA coverage—typical non-purulent cellulitis is primarily streptococcal and responds to beta-lactams in 96% of cases 2
- Ensure adequate drainage before relying on antibiotics for abscesses, as source control is paramount 1
Hospitalized Patients with Complicated SSTI
For severe infections requiring hospitalization, doxycycline is not recommended as it lacks adequate coverage for the broader spectrum needed 1. Preferred agents include: 1
- IV vancomycin
- IV/PO linezolid
- IV daptomycin
- IV telavancin
- IV/PO clindamycin (if local resistance rates are low)